Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -16.8 Million USD | 50.39% |
| 2022 | -35.8 Million USD | 25.94% |
| 2021 | -35.19 Million USD | -40.4% |
| 2020 | -23.25 Million USD | 30.58% |
| 2019 | -41.72 Million USD | -570.45% |
| 2018 | -5.3 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -2.52 Million USD | 27.91% |
| 2023 Q1 | -3.5 Million USD | 30.16% |
| 2023 Q3 | -6.98 Million USD | -176.04% |
| 2023 Q4 | -4.48 Million USD | 35.83% |
| 2023 FY | - USD | 50.39% |
| 2022 Q4 | -5.02 Million USD | -133.34% |
| 2022 Q3 | 15.06 Million USD | 448.62% |
| 2022 FY | - USD | 25.94% |
| 2022 Q2 | -4.32 Million USD | 37.7% |
| 2022 Q1 | -6.93 Million USD | 27.54% |
| 2021 FY | - USD | -40.4% |
| 2021 Q4 | -9.57 Million USD | 6.25% |
| 2021 Q3 | -10.21 Million USD | -19.61% |
| 2021 Q2 | -8.53 Million USD | -33.98% |
| 2021 Q1 | -6.37 Million USD | 0.5% |
| 2020 Q4 | -6.4 Million USD | -54.03% |
| 2020 Q3 | -4.15 Million USD | 41.16% |
| 2020 Q2 | -7.06 Million USD | 0.25% |
| 2020 Q1 | -7.08 Million USD | 57.21% |
| 2020 FY | - USD | 30.58% |
| 2019 Q1 | -4.2 Million USD | 0.0% |
| 2019 FY | - USD | -570.45% |
| 2019 Q3 | -8.68 Million USD | -73.82% |
| 2019 Q4 | -16.55 Million USD | -90.57% |
| 2019 Q2 | -4.99 Million USD | -18.72% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alvotech | -484.86 Million USD | 96.534% |
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 105.45% |
| Journey Medical Corporation | 1.92 Million USD | 974.753% |
| Dynavax Technologies Corporation | 9.66 Million USD | 273.846% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | 89.422% |
| PainReform Ltd. | -9.56 Million USD | -75.609% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -339.387% |
| SCYNEXIS, Inc. | 73.47 Million USD | 122.869% |
| Silver Spike Investment Corp. | 7.34 Million USD | 328.934% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -339.387% |
| Bright Green Corporation | - USD | Infinity% |
| Esperion Therapeutics, Inc. | -150.1 Million USD | 88.805% |
| Aquestive Therapeutics, Inc. | 1.18 Million USD | 1521.658% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | 115.371% |
| Alpha Teknova, Inc. | -25.53 Million USD | 34.203% |
| Embecta Corp. | 245.4 Million USD | 106.848% |
| Safety Shot Inc | -12.18 Million USD | -37.905% |
| Procaps Group, S.A. | 104.02 Million USD | 116.153% |
| Cosmos Health Inc. | -17.06 Million USD | 1.511% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | -614.757% |
| Pacira BioSciences, Inc. | 162.89 Million USD | 110.316% |
| Theratechnologies Inc. | -10.31 Million USD | -62.943% |
| Harrow Health, Inc. | 9.72 Million USD | 272.827% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | -271.359% |
| Biofrontera Inc. | -18.45 Million USD | 8.936% |
| DURECT Corporation | -24.68 Million USD | 31.924% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | 117.101% |
| Cronos Group Inc. | -72.14 Million USD | 76.709% |
| OptiNose, Inc. | -15.55 Million USD | -8.043% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 98.183% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | 53.428% |
| RedHill Biopharma Ltd. | 26.26 Million USD | 163.976% |
| Organogenesis Holdings Inc. | 36.03 Million USD | 146.638% |
| Guardion Health Sciences, Inc. | -3.92 Million USD | -328.416% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | -2263.931% |
| Radius Health, Inc. | 38.31 Million USD | 143.863% |
| Universe Pharmaceuticals INC | -3.21 Million USD | -422.664% |
| ProPhase Labs, Inc. | -14.82 Million USD | -13.334% |
| Phibro Animal Health Corporation | 84.6 Million USD | 119.861% |
| Procaps Group S.A. | 104.02 Million USD | 116.153% |
| TherapeuticsMD, Inc. | -8.4 Million USD | -100.024% |
| Viatris Inc. | 3.51 Billion USD | 100.478% |
| Rockwell Medical, Inc. | -4.69 Million USD | -257.989% |
| Aytu BioPharma, Inc. | -1.01 Million USD | -1560.474% |
| SIGA Technologies, Inc. | 84.15 Million USD | 119.967% |
| Tilray Brands, Inc. | -72.84 Million USD | 76.931% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | 2169.458% |
| Shineco, Inc. | -26.55 Million USD | 36.717% |
| PetIQ, Inc. | 81.48 Million USD | 120.622% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | -364.503% |
| Incannex Healthcare Limited | -18.5 Million USD | 9.187% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 104.038% |
| Alimera Sciences, Inc. | 7.27 Million USD | 330.951% |
| Assertio Holdings, Inc. | -222.44 Million USD | 92.446% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | -321.084% |
| Petros Pharmaceuticals, Inc. | -4.21 Million USD | -298.968% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 16.109% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | 88.732% |
| Hempacco Co., Inc. | -12.77 Million USD | -31.556% |
| Talphera, Inc. | -9.84 Million USD | -70.738% |
| Alvotech | -484.86 Million USD | 96.534% |
| Eagle Pharmaceuticals, Inc. | 77.5 Million USD | 121.682% |
| Lantheus Holdings, Inc. | 491 Million USD | 103.422% |
| Currenc Group, Inc. | -1.9 Million USD | -784.154% |
| Kamada Ltd. | 21.53 Million USD | 178.035% |
| Indivior PLC | 66 Million USD | 125.461% |
| Evoke Pharma, Inc. | -7.29 Million USD | -130.435% |
| Flora Growth Corp. | -45.87 Million USD | 63.366% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 16.109% |
| Evolus, Inc. | -41.81 Million USD | 59.809% |
| HUTCHMED (China) Limited | 25.52 Million USD | 165.826% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | 106.959% |
| Akanda Corp. | -27.73 Million USD | 39.414% |